Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration approved Takeda Pharmaceuticals America Inc.’s Mimrylo for adults with polycythemia vera whose disease is not adequately controlled with existing therapy, introducing a …
FDA Approves Mimrylo to Cut Phlebotomy Need in Blood Disorder Read More
WASHINGTON, D.C. — U.S. regulators authorized Abbott Diabetes Care’s Libre Duo 10 Day for people with diabetes aged 2 and older, introducing the first U.S. wearable capable of continuously monitoring …
FDA Clears Abbott Device to Continuously Track Ketones, Glucose Read More WASHINGTON, D.C. — The Food and Drug Administration last week authorized the first standalone robotic device capable of drawing blood without hands-on operator intervention, allowing a single trained phlebotomist to …
FDA Clears Robotic Blood Draws to Ease Staffing Shortages Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration has cleared the first over-the-counter continuous glucose monitor for children, expanding access to glucose-tracking technology as rates of prediabetes and Type …
FDA Expands OTC Glucose Monitor Access to Children Read More